✨ Medicine Consent Notices
1 APRIL 2004
NEW ZEALAND GAZETTE, No. 39
981
Product:
Lipitor
Active Ingredient:
Atorvastatin calcium 86.76mg equivalent to 80mg atorvastatin
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Pfizer New Zealand Limited
Manufacturer:
Parke Davis Pharmaceuticals Limited, Vega Baja, Puerto Rico
Product:
Seretide Accuhaler
Active Ingredients:
Fluticasone propionate 100µg
Salmeterol xinafoate 72.5µg equivalent to 50µg of salmeterol base
Dosage Form:
Powder for inhalation
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturers:
Glaxo Operations UK Limited, Ware, Hertfordshire, United Kingdom
Glaxo Wellcome Production, Evreux, France
Product:
Seretide Accuhaler
Active Ingredients:
Fluticasone propionate 250µg
Salmeterol xinafoate 72.5µg equivalent to 50µg of salmeterol base
Dosage Form:
Powder for inhalation
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturers:
Glaxo Operations UK Limited, Ware, Hertfordshire, United Kingdom
Glaxo Wellcome Production, Evreux, France
Product:
Seretide Accuhaler
Active Ingredients:
Fluticasone propionate 500µg
Salmeterol xinafoate 72.5µg equivalent to 50µg of salmeterol base
Dosage Form:
Powder for inhalation
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturers:
Glaxo Operations UK Limited, Ware, Hertfordshire, United Kingdom
Glaxo Wellcome Production, Evreux, France
Product:
Seretide
Active Ingredients:
Fluticasone propionate 20mg equivalent to 125µg/dose
Salmeterol xinafoate 5.8mg equivalent to 25µg/dose salmeterol
Dosage Form:
Aerosol inhaler, metered dose
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturers:
Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom
Glaxo Wellcome Production, Evreux, France
Product:
Seretide
Active Ingredients:
Fluticasone propionate 40mg equivalent to 250µg/dose
Salmeterol xinafoate 5.8mg equivalent to 25µg/dose salmeterol
Dosage Form:
Aerosol inhaler, metered dose
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturers:
Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom
Glaxo Wellcome Production, Evreux, France
Product:
Seretide
Active Ingredients:
Fluticasone propionate 8mg equivalent to 50µg/dose
Salmeterol xinafoate 5.8mg equivalent to 25µg/dose salmeterol
Dosage Form:
Aerosol inhaler, metered dose
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturers:
Glaxo Wellcome Operations, Speke, Liverpool, United Kingdom
Glaxo Wellcome Production, Evreux, France
Dated this 29th day of March 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).
go2178
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2004, No 39
Gazette.govt.nz —
NZ Gazette 2004, No 39
✨ LLM interpretation of page content
🏥
Consent to the Distribution of Changed Medicines
(continued from previous page)
🏥 Health & Social Welfare29 March 2004
Medicines, Consent, Changed, Lipitor, Seretide, Atorvastatin, Fluticasone, Salmeterol
- DON MATHESON, Deputy Director-General, Public Health